DexCom Raises FY2026 Sales Guidance from $5.180B-$5.250B to $5.200B-$5.250B vs $5.229B Est
Benzinga Newsdesk 3 days ago
NewsGuidance
DexCom (NASDAQ:DXCM) raises FY2026 sales outlook from $5.180 billion-$5.250 billion to $5.200 billion-$5.250 billion vs $5.229 billion estimate.
DexCom (NASDAQ:DXCM) raises FY2026 sales outlook from $5.180 billion-$5.250 billion to $5.200 billion-$5.250 billion vs $5.229 billion estimate.